Blue Ridge Capital’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
|
|||||
|
2017
Q4 | $170M | Sell |
|
|||||
|
2017
Q3 | $180M | Buy |
|
|||||
|
2017
Q2 | $110M | Sell |
|
|||||
|
2017
Q1 | $81.5M | Buy |
|
|||||
|
2016
Q4 | $49.4M | Hold |
|
|||||
|
2016
Q3 | $89.5M | Hold |
|
|||||
|
2016
Q2 | $73.2M | Buy |
|
|||||
|
2016
Q1 | $67.5M | Hold |
|
|||||
|
2015
Q4 | $101M | Hold |
|
|||||
|
2015
Q3 | $86.4M | Hold |
|
|||||
|
2015
Q2 | $129M | Buy |
|
|||||
|
2015
Q1 | $100M | Buy |
|
|||||
|
2014
Q4 | $41.7M | Buy |
|